Clinical perspective SGLT2is and GLP-1RAs exhibit clinical benefits on glycemic control, systolic blood pressure (SBP), body weight, and dyslipidemia, which may all partly contribute to the cardiovascular protection provided by these two drug classes [4, 19]
Chandrasekhar, K., Kapoor, J., & Anishetty, S
So its really important for patients to get a good handle on their blood sugar, and we have a multitude of medications that can help get them there now. Michael Kane, PharmD, diabetes and osteoporosis expert
Download the file to print out the infographic
Metformin has shown some cardiovascular benefits in earlier studies, though evidence from modern cardiovascular outcome trials is inconsistent
For a personalised consultation and to book this treatment, book your IV drip session here